SKYDD Biotechnology

SKYDD Biotechnology is an Australian biotechnology company headquartered in Melbourne, specializing in the development of natural virus prevention solutions. The company's core technology utilizes IgY antibody engineering, derived from egg yolks, to create a protective barrier in the human respiratory tract against viral pathogens. Its lead product, a pocket-sized Anti-Virus Spray, is designed to provide up to four hours of protection against COVID-19, Influenza A and B, and Respiratory Syncytial Virus (RSV). SKYDD operates within the Jumar Biotechnology Incubator at the CSL head office and collaborates with leading health institutions to advance its clinical pipeline. The company is currently conducting human clinical trials in Australia with the goal of obtaining TGA and FDA approvals.